Search

everythinglearnresearchcommunity

for

Search:↓

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

A man had bad reactions to a hair loss treatment called DNCB.

Adriamycin and ifosfamide together work best for advanced soft tissue sarcomas.

Oncology specialists are disappointed by the discontinuation of the effective lymphoma treatment Bexxar.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

Non-myeloablative stem cell transplants are a promising, less toxic option for older or weaker patients, with fewer side effects and good outcomes.

People with Birt-Hogg-Dubé syndrome often have lung problems and delayed diagnosis, and better recognition of CT scan signs could improve diagnosis and management.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Antituberculosis drugs can cause severe skin reactions, requiring careful diagnosis and treatment.

Long-term exposure to benzene increases skin diseases, blood disorders, and liver problems.

Mycophenolate mofetil improved skin condition in a man with nephrogenic fibrosing dermopathy.

Combining TCA with 5-FU is more effective and safer for treating keloids than TCA alone.

Fusaric acid may help control Orobanche ramosa by activating plant defenses.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

The hydrogel helps heal wounds without scars by releasing two drugs gradually.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

PUVA-turban therapy can help some people with severe alopecia areata regrow hair.

Skin ulcers from interferon may not depend on the amount given.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Finasteride may help treat childhood brain tumors by activating certain genes.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

A chemical called 5-Bromo-2′-deoxyuridine caused rapid hair loss in mice by killing certain skin cells through a specific cell death pathway.

Terbinafine can cause skin reactions when exposed to sunlight, so sun exposure should be avoided during treatment.